Alejandro Folch Sandoval, MD @alejandrofolch X Profile

Alejandro Folch Sandoval, MD

@alejandrofolch

Followers

460

Following

5K

Media

18

Statuses

1K

Transplant cardiologist @UThealthSA. Alumn @mountsinaiheart @umasscardio @bmcimres. F1 & Tennis enthusiast 🏎️🎾. Tweets are my own

San Antonio, TX

Joined July 2011

Don't wanna be here? Send us removal request.

Ross Prager

@ross_prager

1 year

I hear clinicians say the physical exam is dead.☠️ This is just not true 🛑 Here are the 10 most important clinical exam findings in the ICU A 🧵 (and some things you can probably stop doing...) #medtwitter #foamed

46

536

2K

Muhammad Saad

@MsMsaad088

2 years

Wow..Can't believe this is a dream come true!!! My 3rd book in a row with legendary Dr Samin Sharma and Mc-Graw Hill Publications. @MountSinaiHeart @dranulala @SinaiCards @NavinKapur4 @TuftsMedicalCtr @MHEducation @JeirymMirandaMD @HollandTamis. https://t.co/fEf3eTdNBq

4

5

21

David Juurlink

@DavidJuurlink

2 years

Losartan is a prodrug with two active metabolites, both of which have weirdly cryptic names. Most of the hypotensive response is mediated by EXP3174 (usually abbreviated E-3174). /2 https://t.co/RnQ2A20GwQ

1

7

66

Alejandro Folch Sandoval, MD

@alejandrofolch

2 years

Late post but I am so proud of my friend and mentor @Jcontreras75 for her very deserved award from the Colombian Society of Cardiology!!

1

0

8

TIME

@TIME

2 years

Tens of thousands rail against Mexico's President and ruling party in 'march for democracy'

289

4K

9K

C. Michael Gibson MD

@CMichaelGibson

2 years

ARIES-HM3 Trial: In patients with HF receiving HM3 LVAD, VKA alone without aspirin results in no change in thrombotic outcomes, significantly less bleeding and less hospitalizations. Download slides for the ARIES-HM3 trial on excluding aspirin in LVAD HM3 presented at #AHA23

0

67

162

American College of Cardiology

@ACCinTouch

2 years

In patients w/ #HeartFailure who receive a primary prev ICD, the risk of developing atrial arrhythmia is influenced by the type of beta-blocker treatment. Carvedilol can significantly ↘️ the risk of atrial arrhythmias compared to metoprolol. https://t.co/8Wxb2iw88m #JACCCEP

1

92

268

Alejandro Folch Sandoval, MD

@alejandrofolch

2 years

It’s been a week! I rarely post about my personal life but this one is worth it. My best friend agreed to spend the rest of our lives together Thank you @paosmeade for your unconditional love and support. I can’t wait for all the laughs, stories and adventures by your side

6

1

86

Alejandro Folch Sandoval, MD

@alejandrofolch

2 years

So grateful to have learned heart failure from giants in the field for the past year @MountSinaiHeart . Thank you @DonnaMancini11 and @dranulala for all the teaching, mentorship and patience! @M_CagliostroMD

1

33

Carlos G Santos-Gallego, MD

@SantosGallegoMD

2 years

Breaking news: FDA has just approved sotagliflozin (brand name "Inpefa") for Treatment of Heart Failure!!!! Broad label across full LVEF range (HFpEF&HFrEF), and for patients with or without T2DM First dual SGLT1/2 inhibitor to be approved in HF @DLBHATTMD @ChristosArgyrop

11

259

669

Matt Burrage

@DrMattBurrage

2 years

Great to see our work on DBD and DCD HTx🫀from @royalpapworth just published in @JCardFail We wanted to see if there were any differences between DBD and DCD HTx and controls in terms of cardiac mechanics and myocardial fibrosis on #whyCMR https://t.co/WcYyYuQcX2 🧵 1/n

2

48

115

Alejandro Folch Sandoval, MD

@alejandrofolch

2 years

I asked a yes/no question this weekend. I’m so happy @paosmeade said yes 😁👰🏻‍♀️🤵🏻

Paola Suárez Meade, MD

@paosmeade

2 years

I usually don’t post about my personal life, but this one definitely makes the cut!! I’m marrying my best friend and the most amazing human being on earth @alejandrofolch!! Can’t wait for forever!